- Funder
- National Cancer Institute (NCI)
- Funding amount
- Varies
- Deadline
- Nov 5, 2026
- Location
- N/A
Grant Overview
NCI Investigator-Initiated Early Phase Cancer Clinical Trials Grant is sponsored by National Cancer Institute (NCI). This program provides R01 funding for clinical research evaluating new or improved approaches to cancer diagnosis and treatment.
Grant Eligibility
Public and private institutions of higher education are eligible. Eligible state, local, tribal, and federal government organizations may apply. Foreign/non-U. S. organizations are eligible.